应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
NITE The Nightview Fund
盘后交易 12-16 16:25:11 EST
37.23
+0.09
+0.25%
盘后
37.23
+0.00
0.00%
16:04 EST
最高
37.23
最低
37.04
成交量
324.00
今开
37.04
昨收
37.13
日振幅
0.50%
总市值
3,029万
流通市值
3,029万
总股本
81.38万
成交额
1.20万
换手率
0.04%
流通股本
81.38万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
暂无数据
公司概况
公司名称:
The Nightview Fund
所属市场:
ARCA
上市日期:
--
主营业务:
Nightstar Therapeutics Plc最初于2013年5月根据英格兰和威尔士的法律成立,随后于2014年1月更名为NightstaRx Limited。该公司是一家领先的临床阶段基因治疗公司,专注于开发和治疗药物患有罕见的遗传性视网膜疾病,否则会进入失明。利用他们在眼科,基因治疗和药物开发方面的专业知识,他们正在开发一系列专有产品候选人,旨在大幅度修改或停止目前尚未批准的治疗的遗传性视网膜疾病的进展。他们的任务是维护和通过构建领先的垂直整合视网膜基因治疗公司,恢复患者的视力。
发行价格:
--
{"stockData":{"symbol":"NITE","market":"US","secType":"STK","nameCN":"The Nightview Fund","latestPrice":37.2275,"timestamp":1765918800000,"preClose":37.1333,"halted":0,"volume":324,"hourTrading":{"tag":"盘后","latestPrice":37.2275,"preClose":37.2275,"latestTime":"16:04 EST","volume":2,"amount":74.455,"timestamp":1765919040673},"delay":0,"floatShares":813768,"shares":813768,"eps":0,"marketStatus":"盘后交易","change":0.0942,"latestTime":"12-16 16:25:11 EST","open":37.04,"high":37.2275,"low":37.04,"amount":12000.01392,"amplitude":0.005049,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1765933200000},"marketStatusCode":4,"adr":1,"adrRate":1,"listingDate":1506571200000,"exchange":"ARCA","adjPreClose":37.1333,"sharesOutstanding":813768,"nav":37.1,"aum":30191595.78,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":37.2275,"preClose":37.2275,"latestTime":"16:04 EST","volume":2,"amount":74.455,"timestamp":1765919040673},"volumeRatio":0.209113},"requestUrl":"/m/hq/s/NITE/tweets","defaultTab":"tweets","newsList":[],"profile":{"websiteUrl":"http://www.nightstartx.com","stockEarnings":[{"period":"1week","weight":0.0147},{"period":"1month","weight":0.0623},{"period":"3month","weight":0.0567},{"period":"6month","weight":0.2458},{"period":"1year","weight":0.1898},{"period":"ytd","weight":0.2432}],"compareEarnings":[{"period":"1week","weight":-0.0042},{"period":"1month","weight":0.0131},{"period":"3month","weight":0.0314},{"period":"6month","weight":0.1394},{"period":"1year","weight":0.1266},{"period":"ytd","weight":0.1615}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Nightstar Therapeutics Plc最初于2013年5月根据英格兰和威尔士的法律成立,随后于2014年1月更名为NightstaRx Limited。该公司是一家领先的临床阶段基因治疗公司,专注于开发和治疗药物患有罕见的遗传性视网膜疾病,否则会进入失明。利用他们在眼科,基因治疗和药物开发方面的专业知识,他们正在开发一系列专有产品候选人,旨在大幅度修改或停止目前尚未批准的治疗的遗传性视网膜疾病的进展。他们的任务是维护和通过构建领先的垂直整合视网膜基因治疗公司,恢复患者的视力。","exchange":"ARCA","name":"The Nightview Fund","nameEN":"The Nightview Fund"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"The Nightview Fund(NITE)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供The Nightview Fund(NITE)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"The Nightview Fund,NITE,The Nightview Fund股票,The Nightview Fund股票老虎,The Nightview Fund股票老虎国际,The Nightview Fund行情,The Nightview Fund股票行情,The Nightview Fund股价,The Nightview Fund股市,The Nightview Fund股票价格,The Nightview Fund股票交易,The Nightview Fund股票购买,The Nightview Fund股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"The Nightview Fund(NITE)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供The Nightview Fund(NITE)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}